Leukemia-associated virus immunogen, vaccine and assay
US4794168A · kind A · utility
6Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 1985 |
| Grant date | Dec 27, 1988 |
| Priority date | — |
| Expiry date | Dec 10, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/221
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a leukemia-associated virus immunogens, vaccines, antibody combining sites and assays. The immunogens are relatively short polypeptides with peptide sequences corresponding to the antigenic determinant domains of a leukemia-associated virus envelope protein. The immunogens when introduced into a host stimulate the production of antibodies which immunoreact with the polypeptides and the leukemia-associated virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.